文献速递甲状腺核医学肿瘤 PET/CT

甲状腺癌131I治疗后胆囊及高级别浆液性卵巢腺癌异常摄取一例

Increased 131I Accumulation in the Gallbladder and High-grade Serous Ovarian Adenocarcinoma.
PubMed 文献 · Clin Nucl Med · 2019-01-01

一例55岁女性甲状腺乳头状癌患者在接受全甲状腺切除及3程131I治疗后,第三次治疗后全身扫描显示右上腹(与肝脏重叠)及盆腔异常131I摄取,SPECT/CT定位为增大的胆囊和盆腔囊实性肿块,病理证实为双侧高级别浆液性卵巢腺癌。

要点

  • 甲状腺癌131I治疗后扫描中胆囊和卵巢腺癌摄取131I属罕见。
  • SPECT/CT有助于定位131I异常摄取灶并鉴别生理性与病理性。
  • 盆腔囊实性肿块伴131I摄取时需警惕卵巢来源肿瘤。

核心结论

  • 甲状腺癌患者131I治疗后扫描可出现胆囊及高级别浆液性卵巢腺癌的异常131I摄取。

研究设计与样本

  • 个案报道:一例55岁女性甲状腺乳头状癌患者,接受全甲状腺切除及3程131I治疗。

主要发现

  • 第三次131I治疗后全身扫描显示右上腹(与肝脏重叠)及盆腔异常131I摄取。
  • 进一步SPECT/CT显示摄取来自增大的胆囊和盆腔巨大囊实性肿块。
  • 盆腔肿块病理证实为双侧高级别浆液性卵巢腺癌。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is unusual to observe I accumulation in the gallbladder and high-grade serous ovarian adenocarcinoma during posttherapeutic I scan. We report the case of a 55-year-old woman with papillary thyroid cancer, who received total thyroidectomy and then 3 courses of I therapy. The posttherapeutic whole-body scan after the third dose of I therapy revealed abnormal I uptake in the right upper abdomen, overlapping the liver, and the pelvis. Further SPECT/CT imaging found that they were from an enlarged gallbladder and a large pelvic complex solid and cystic mass, which was pathologically confirmed as bilateral high-grade serous ovarian adenocarcinoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yao X, Wang J, Xia M, et al. Increased 131I Accumulation in the Gallbladder and High-grade Serous Ovarian Adenocarcinoma. Clin Nucl Med. 2019. PMID: 30371583. doi:10.1097/RLU.0000000000002339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。